Distinct and Convergent Roles of the Synovial Sarcoma X Breakpoint Family of Cancer-Testis Antigens in Ovarian Cancer.
- 1Centre for Biomedicine, Hull York Medical School, University of Hull, Hull HU6 7RX, UK.
- 2Wound Innovation Institute, University of Hull, Hull HU6 7RX, UK.
Abstract
Ovarian cancer (OC) is a leading cause of death in women, with limited advances in diagnosis and treatment over the past decade. The Synovial Sarcoma, X Breakpoint (SSX) family of cancer-testis antigens represent promising biomarkers and immunotherapeutic targets; however, the functions of individual SSX family members remain poorly defined due to their high sequence similarity. We investigated the roles of SSX2A, SSX2B and SSX3 using RNA sequencing, in vitro and in vivo assays. Pathway analysis revealed involvement in nucleosome assembly, calcium signalling, and cellular stress responses, alongside increased OC cell proliferation in vitro following overexpression. Additionally, SSX variants altered key epithelial-mesenchymal transition (EMT) associated markers, including upregulation of the transcription factor, SLUG. Integration with patient transcriptomic datasets identified several SSX regulated genes associated with overall survival (OS). These findings suggest that SSX family members are not functionally redundant and may contribute to OC progression and clinical outcome.
Related
- Tendon grafting using Gracilis and semitendinosus tendons for extensive flexor tendon defects following synovial sarcoma excision: A case report
- Beyond the Bones: Primary Prostatic Synovial Sarcoma in a Young Adult
- Aggressive primary mediastinal synovial sarcoma resulting in catastrophic airway compromise and fatal hemoptysis
- Primary Renal Synovial Sarcoma Mimicking Transitional Cell Carcinoma: A Case Report.
- Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters
BibTeX
@article{grayson2026distinct,
title = {{Distinct and Convergent Roles of the Synovial Sarcoma X Breakpoint Family of Cancer-Testis Antigens in Ovarian Cancer.}},
author = {Kelly C Grayson and Holly N Wilkinson and John D Wright and Stephen J Archibald and Matthew J Hardman and Barbara-Ann Guinn},
journal = {International journal of molecular sciences},
year = {2026},
month = sep,
doi = {10.3390/ijms27198608},
url = {https://europepmc.org/article/MED/42883856},
note = {CC BY},
}
RIS
TY - JOUR
TI - Distinct and Convergent Roles of the Synovial Sarcoma X Breakpoint Family of Cancer-Testis Antigens in Ovarian Cancer.
AU - Kelly C Grayson
AU - Holly N Wilkinson
AU - John D Wright
AU - Stephen J Archibald
AU - Matthew J Hardman
AU - Barbara-Ann Guinn
PY - 2026
DA - 2026/09/26
JO - International journal of molecular sciences
DO - 10.3390/ijms27198608
UR - https://europepmc.org/article/MED/42883856
AB - Ovarian cancer (OC) is a leading cause of death in women, with limited advances in diagnosis and treatment over the past decade. The Synovial Sarcoma, X Breakpoint (SSX) family of cancer-testis antigens represent promising biomarkers and immunotherapeutic targets; however, the functions of individual SSX family members remain poorly defined due to their high sequence similarity. We investigated the roles of SSX2A, SSX2B and SSX3 using RNA sequencing, in vitro and in vivo assays. Pathway analysis revealed involvement in nucleosome assembly, calcium signalling, and cellular stress responses, alongside increased OC cell proliferation in vitro following overexpression. Additionally, SSX variants altered key epithelial-mesenchymal transition (EMT) associated markers, including upregulation of the transcription factor, SLUG. Integration with patient transcriptomic datasets identified several SSX regulated genes associated with overall survival (OS). These findings suggest that SSX family members are not functionally redundant and may contribute to OC progression and clinical outcome.
SN - 1422-0067
ER -